European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 20, Status: Authorised

Submitted by Anonymous (not verified) on 13 May 2026 - 8:41

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 20, Status: Authorised

Herbal medicinal product: Fragariae folium, Fragaria vesca L., Fragaria moschata Weston,Fragaria viridis Weston,Fragaria x ananassa (Weston) Duchesne ex Rozier , F: Assessment finalised

Submitted by Anonymous (not verified) on 12 May 2026 - 16:38

Herbal medicinal product: Fragariae folium, Fragaria vesca L., Fragaria moschata Weston,Fragaria viridis Weston,Fragaria x ananassa (Weston) Duchesne ex Rozier , F: Assessment finalised

Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 12 May 2026 - 16:25

Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 12 May 2026 - 15:20

Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 12 May 2026 - 15:08

Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 9, Status: Authorised

Submitted by Anonymous (not verified) on 12 May 2026 - 15:00

Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 9, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness